Masahiro Yahata

机构：Sumitomo Dainippon Pharma (Japan), Sumitomo Dainippon Pharma (United States) · ORCID：0000-0002-9528-9913

发表论文 53 篇 · 总被引 329 次 · h-index 11

代表论文

• Biodistribution studies for cell therapy products: Current status and issues (2021 · Regenerative Therapy · 被引 28)
• Attenuation of 2,3,7,8-Tetrachlorodibenzo-p-dioxin Toxicity by Resveratrol: A Comparative Study with Different Routes of Administration (2009 · Biological and Pharmaceutical Bulletin · 被引 23)
• Effects of subvolcanic hydrothermal systems on edifice collapses and phreatic eruptions at Tokachidake volcano, Japan (2018 · Journal of Volcanology and Geothermal Research · 被引 20)
• N-(6-phenylpyridazin-3-yl)benzenesulfonamides as highly potent, brain-permeable, and orally active kynurenine monooxygenase inhibitors (2020 · Bioorganic & Medicinal Chemistry Letters · 被引 15)
• Petrological assessment of drying shrinkage of sedimentary rock used as aggregates for concrete (2021 · Materials & Design · 被引 7)
• Prediction methods of drug-drug interactions of non-oral CYP3A4 substrates based on clinical interaction data after oral administrations – Validation with midazolam, alfentanil, and verapamil after intravenous administration and prediction for blonanserin transdermal patch (2020 · Drug Metabolism and Pharmacokinetics · 被引 7)